April 21, 2021 Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of India has introduced a new draft General Chapter on ‘Approach to Alternative Rapid Microbiological Method’. The proposed methods would enable faster laboratory testing of the…

Oct, 24 2020 Gilead Lifesciences Inc.'s Veklury (Remdesivir) has become the first treatment for COVID-19 to receive the U.S. Food and Drug Administration approval. The drug is approved for use in adult and pediatric patients 12 years of age and older…

July 6, 2020 Gilead Sciences has announced that the European Commission has granted conditional marketing authorization for Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. The conditional marketing authorization was granted in the interest of public…
Recent Post
- 🚨 CDSCO Issues Urgent Directive for Stopping manufacturing and marketed of Unapproved FDCs – What Pharma Manufacturers Need to Know
- 📊 Unlocking Opportunity: Comprehensive Market Research Reports Now Available at Vaayath Consulting
- 🌐Ease of Doing Business: CDSCO introduces new Updates regarding the Auto-generated Market standard Certificate (MSC) and Non-Conviction Certificate (NCC) for Licenced Medical devices.
- Complete List of Banned Drugs in India
- Government Mandates Online CRO Registration via SUGAM Portal!